OTC Markets OTCPK - Delayed Quote USD

Nippon Shinyaku Co., Ltd. (NPNKF)

Compare
55.55 +13.73 (+32.83%)
At close: December 6 at 3:00:00 PM EST
Loading Chart for NPNKF
DELL
  • Previous Close 41.82
  • Open 55.55
  • Bid 25.34 x --
  • Ask 30.34 x --
  • Day's Range 41.82 - 41.82
  • 52 Week Range 41.82 - 55.55
  • Volume 12,191
  • Avg. Volume 0
  • Market Cap (intraday) 3.743B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 20.13
  • EPS (TTM) 2.76
  • Earnings Date Feb 7, 2025 - Feb 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

www.nippon-shinyaku.co.jp

2,213

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NPNKF

View More

Performance Overview: NPNKF

Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NPNKF
7,317.35%
Nikkei 225
17.95%

1-Year Return

NPNKF
7,317.35%
Nikkei 225
19.87%

3-Year Return

NPNKF
18,082,695.00%
Nikkei 225
37.81%

5-Year Return

NPNKF
35.41%
Nikkei 225
64.30%

Compare To: NPNKF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NPNKF

View More

Valuation Measures

Annual
As of 12/13/2024
  • Market Cap

    1.83B

  • Enterprise Value

    1.41B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    2.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NPNKF

View More

Company Insights: NPNKF

Research Reports: NPNKF

View More

People Also Watch